Clinical impact of SPECT-CT in the diagnosis and surgical management of hyper-parathyroidism

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 4, 2014, Pages 1028-1034

  Tokmak, Handan ^a   Demirkol, Mehmet Onur ^a   Alagöl, Faruk ^a   Tezelman, Serdar ^a   Terzioglu, Tarik ^a  

^a AMERICAN HOSPITAL   (Turkey)

Author keywords

Hyper parathyroidism; Minimally invasive parathyroidectomy; Parathyroid adenoma; Parathyroid scintigraphy; SPECT CT

Indexed keywords

METHOXYISOBUTYLISONITRILE TECHNETIUM 99M; SESTAMIBI TECHNETIUM TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; CALCIUM BLOOD LEVEL; CT SPECT SCANNER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PREDICTIVE VALUE; SCINTIGRAPHY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

EID: 84900423340     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ruda JM, Hollenbeak C, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyper-parathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005; 132: 359-372.
2. AACE/AAES Task Force on Primary Hyper-parathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position sta-tement on the diagnosis and management of primary hyper-parathyroidism. Endocr Pract 2005; 11: 49-54.
3. Suliburk JW, Perrier ND. Primary hyperparathyroidism. Oncologist 2007; 12: 644-63.
4. Fraser WD. Hyper-parathyroidism. Lancet 2009; 374: 145-148.
5. Bilezikian JP, Silverberg SJ. Clinical practice. Asymptomatic primary hyper-parathyroidism. N Engl J Med 2004; 350: 1746-1751.
6. Sitges-Serra A, Bergenfelz A. Clinical update: sporadic primary hyper-parathyroidism. Lancet 2007; 370: 468-470.
7. Taniegra ED. Hyper-parathyroidism. Am Fam Physician 2004; 69: 333-339.
8. Satava RM, Beahrs OH, Scholz DA. Success rate of cervical exploration for hyper-parathyroidism. Arch Surg 1975; 110: 625-627.
9. Mekel M, Mahajna A, Ish-Shalom S, Barak M, Segal E, Salih AA, Bishara B, Shen-Or Z, Krausz MM. Minimally invasive surgery for treatment of hyper-parathyroidism. Isr Med Assoc J 2005; 7: 323-327.
10. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyper-parathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo clinic experience. Arch Surg 2005; 140: 472-479.
11. Russell C. Unilateral neck exploration for primary hyper-parathyroidism. Surg Clin North Am 2004; 84: 705-716.
12. Howe JR. Minimally invasive parathyroid surgery. Surg Clin North Am 2000; 80: 1399-1426.
13. Carling T, Udelsman R. Focused approach to parathyroidectomy. World J Surg 2008; 32: 1512-1517.
14. Lew JI, Solorzano CC. Surgical management of primary hyper-parathyroidism: state of the art. Surg Clin North Am 2009; 89: 1205-1225.
15. Lumachi F, Tregnaghi A, Zucchetta P, Marzola MC, Cecchin D, Marchesi P, Bui F, Iacobone M. Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyper-parathyroidism: a prospective clinical study. Br J Radiol 2004; 77: 100-103.
16. Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Technetium 99m MIBI-SPECT: a highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000; 128: 29-35.
17. Slater A, Gleeson FV. Increased sensitivity and confidence of SPECT over planar imaging in dual phase sestamibi for parathyroid adenoma detection. Clin Nucl Med 2005; 30: 1-3.
18. Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003; 44: 904-908.
19. Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Preoperative localization of parathyroid adenomas using 99mTc-MIBI scintigraphy. Am J Med 2000 Jun 15; 108: 733-736.
20. Slater A, Gleeson FV. Increased sensitivity and confidence of SPECT over planar imaging in dual phase sestamibi for parathyroid adenoma detection. Clin Nucl Med 2005; 30: 1-3.
21. Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyper-parathyroidism. Surgery 2002; 131: 149-157.
22. Perez-Monte JE, Brown ML, Shah AN, Ranger NT, Watson CG, Carty SE, Clarke MR. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology 1996; 201: 85-91.
23. Profanter C, Wetscher GJ, Gabriel M, Sauper T, Rieger M, Kovacs P, Bale R, Prommegger R. CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyper-parathyroidism. Surgery 2004; 135: 157-162.
24. Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, Ochoa BB, Moxley DM, Erwin WD, Podoloff DA. The value of 99m-Tc-sestamibi SPECT-CT over conventional SPECT in the evaluation of parathyroid adenomas and hyperplasia. J Nucl Med 2005; 46: 248-252.
25. Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R, Even-Sapir E, Chisin R, Israel O. Technetium-99m-MIBI SPECT-CT in primary hyper-parathyroidism. World J Surg 2006; 30: 76-83.
26. Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol 2010; 65: 278-287.